Eli Lilly and Stock Forecast, Price & News

Eli Lilly and's stock was trading at $140.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LLY stock has increased by 3.4% and is now trading at $144.75.
View which stocks have been most impacted by COVID-19.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly and in the last year. There are currently 5 hold ratings, 9 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eli Lilly and.

Wall Street analysts have given Eli Lilly and a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eli Lilly and wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Eli Lilly and is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Eli Lilly and.

Eli Lilly and Company (NYSE:LLY) posted its quarterly earnings results on Sunday, November, 1st. The company reported $1.54 earnings per share for the quarter, missing the consensus estimate of $1.71 by $0.17. The business earned $5.74 billion during the quarter, compared to analysts' expectations of $5.87 billion. Eli Lilly and had a return on equity of 166.45% and a net margin of 24.01%. The business's revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.48 earnings per share.
View Eli Lilly and's earnings history.

Eli Lilly and declared a quarterly dividend on Monday, October 19th. Investors of record on Friday, November 13th will be paid a dividend of $0.74 per share on Thursday, December 10th. This represents a $2.96 annualized dividend and a yield of 2.04%. The ex-dividend date is Thursday, November 12th.
View Eli Lilly and's dividend history.

Eli Lilly and issued an update on its FY20 earnings guidance on Tuesday, October, 27th. The company provided EPS guidance of $7.20-$7.40 for the period, compared to the Thomson Reuters consensus estimate of $7.29. The company issued revenue guidance of $23.7-$24.2 billion, compared to the consensus revenue estimate of $23.79 billion.

15 Wall Street analysts have issued twelve-month price targets for Eli Lilly and's stock. Their forecasts range from $144.00 to $200.00. On average, they anticipate Eli Lilly and's share price to reach $168.93 in the next twelve months. This suggests a possible upside of 16.7% from the stock's current price.
View analysts' price targets for Eli Lilly and.

Eli Lilly and saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 5,280,000 shares, an increase of 40.1% from the September 30th total of 3,770,000 shares. Based on an average daily volume of 3,300,000 shares, the days-to-cover ratio is presently 1.6 days. Approximately 0.7% of the shares of the stock are sold short.
View Eli Lilly and's Short Interest.

Some companies that are related to Eli Lilly and include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT) and Endo International (ENDP).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly and investors own include Johnson & Johnson (JNJ), Pfizer (PFE), NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Bristol-Myers Squibb (BMY), The Walt Disney (DIS), AT&T (T), Verizon Communications (VZ) and JPMorgan Chase & Co. (JPM).

Eli Lilly and trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly and's stock is owned by a number of institutional and retail investors. Top institutional investors include Lilly Endowment Inc. (11.62%), BlackRock Inc. (6.32%), State Street Corp (3.65%), Nuveen Asset Management LLC (0.82%), Fisher Asset Management LLC (0.49%) and Jennison Associates LLC (0.48%). Company insiders that own Eli Lilly and stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, David A Ricks, Donald A Zakrowski, Enrique A Conterno, Jackson P Tai, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry.
View institutional ownership trends for Eli Lilly and.

LLY stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, BlackRock Inc., State Street Corp, Lilly Endowment Inc., Massachusetts Financial Services Co. MA, Charles Schwab Investment Management Inc., Los Angeles Capital Management & Equity Research Inc., and Schafer Cullen Capital Management Inc. Company insiders that have sold Eli Lilly and company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Lilly Endowment Inc, Melissa S Barnes, Myles O'neill, and Stephen F Fry.
View insider buying and selling activity for Eli Lilly and.

LLY stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., First Trust Advisors LP, State of Tennessee Treasury Department, Acadian Asset Management LLC, Arrowstreet Capital Limited Partnership, Jupiter Asset Management Ltd., Sirios Capital Management L P, and DekaBank Deutsche Girozentrale. Company insiders that have bought Eli Lilly and stock in the last two years include Anne E White, David A Ricks, Jackson P Tai, and Joshua L Smiley.
View insider buying and selling activity for Eli Lilly and.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $144.75.

Eli Lilly and has a market capitalization of $138.47 billion and generates $22.32 billion in revenue each year. The company earns $8.32 billion in net income (profit) each year or $6.04 on an earnings per share basis. Eli Lilly and employs 33,625 workers across the globe.

The official website for Eli Lilly and is www.lilly.com.

Eli Lilly and's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]